Tada joined Astellas Venture Management (AVM) in April 2018. Tada has been involved in multiple investments, including Mogrify as well as emerging technology companies in the field of in vivo cell engineering, cellar rejuvenation, full tooth regeneration etc. Prior to which he worked in Innovation Management at Astellas Pharma Inc. from 2016-2018, in charge of business transaction for early stage partnering deals. From 2009 – 2016, he worked for Clinical Pharmacology Department at Astellas Pharma Inc. taking a lead in preparing early-stage clinical development plans. He also led clinical study protocol preparation and data analysis, and coordinated and managed preparation of applications for Clinical Pharmacology components, including Briefing Documents, INDs and NDAs and represented as a Clinical Pharmacology representative to the relevant regulatory authorities. He started his career as a Research Scientist at MSD (Former Banyu Pharmaceutical co., LTD. a subsidiary of Merck & Co., Inc.) in April 2005 with background on pharmacokinetics and molecular biology.